Comparing two blood filtering methods' effect on clotting
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study compares two ways of filtering your blood (plasmapheresis) to see how each affects your blood's ability to clot. If you already receive regular plasmapheresis with citrate, you might help doctors learn which method is safer for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You get regular plasmapheresis (blood filtering) treatments at least every 10 days.
- Your plasmapheresis uses citrate to prevent clotting during treatment.
- You do not take blood thinners (like warfarin, apixaban, or aspirin).
- You are not being treated for high cholesterol, high triglycerides, blood thickness, acquired hemophilia, or nephrotic syndrome.
- You are not pregnant, breastfeeding, or in another study's exclusion period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to prevent blood clots during a specific type of kidney dialysis called hemodiafiltration. If you have end-stage kidney disease and receive dialysis three times a week, this study may help doctors find the safest anticoagulation method for you.
This trial tests a new plasma filter, PX2, used in a procedure called therapeutic plasma exchange (TPE) to clean harmful substances from your blood. It’s for people who already need TPE and can safely use a blood thinner during the treatment.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
This study looks at how well a blood test (PFA-200) works to check clotting in people who take different types of blood thinners. You don't need any extra procedures—just your regular blood draw.
This trial tests whether a higher volume of plasma exchange (cleaning the blood to remove toxins) works better than the standard amount for children with acute liver failure who are not improving with usual care.
Hear when a new Hyperfibrinogenemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.